Micah Tapman
Founder & Partner @ CanopyBoulder
Boulder, United States
Micah Tapman is a seed investor at CanopyBoulder in Boulder focused on Cannabis and Agriculture. Micah Tapman is the Founder and CEO of The Tapman Group. He previously worked at Trym as a Director. Micah Tapman attended The George Washington University School of Business.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Micah Tapman invests in
Stages Micah Tapman invests in
Countries Micah Tapman invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Cannabis 3 (43%)
- Agriculture 2 (29%)
- Biotechnology 2 (29%)
- Market Research 2 (29%)
- AgTech 1 (14%)
Stage
- Seed 2 (29%)
- Series A 1 (14%)
- Series B 1 (14%)
- Funding Round 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Flourish Software is a supply chain management “seed to sale tracking” platform built for cannabis and hemp.The platform is used by cannabis and hemp cultivators, manufacturers, processors, and retailers to track products from seed to sale, manage operations, and leverage advanced analytics. It is designed to manage the day to day operationsbetter, gain valuable insights for cannabis operation, and helps make data-driven decisions.Bennett Adams, Colton Griffin, and Juan Carlos Garcia established the company in Atlanta, Georgia in 2017. | $2.1M / Seed / Aug 06, 2019 | ||
| PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Our technology allows test labs to conduct between 12- 48 tests in parallel, testing up to 20 pathogens per test in less than a days’ shift. This is done at a fraction of the cost of plate counts or RealtimePCR. Our Raw Sample technology allows laboratories to bypass almost 20 steps that Real-time PCR must perform for DNA extraction and purification. PathogenDx technology bypasses the need for purification, quantitation, and normalization increasing the speed and affordability of pathogen screening. This helps our customers reduce testing time by 12 hours on the front end, and avoid spending money on sample prep kits and additional instrumentation. | $3.4M / Series A / Jul 17, 2018 | ||
| BDSA they provides retailers, manufacturers, brands, wholesalers, and investors with actionable insights to drive profitability, increase revenues, and improve stockholdings. | $3.5M / Series B / May 21, 2018 | ||
| Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $3M / Seed / Sep 20, 2017 | ||
| Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $50K / Seed / May 16, 2016 | ||
| Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers. | $20K / Seed / Mar 01, 2016 | ||
| See all 7 investments → | |||
Co-Investors
About CanopyBoulder
CanopyBoulder is a mentorship-driven seed-stage business accelerator and investment fund.
CanopyBoulder Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alan Kane
Mentor
|
|||
Brian Seckel
Mentor
|
|||
Christian Nitu
Mentor
|
|||
|
Daniel Kim
Cohort Fellow - Summer 2019
|
|||
Mark A. Nottoli
Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Micah Tapman invest in?
Micah Tapman invests primarily in Cannabis, Agriculture and Biotechnology startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Micah Tapman?
Public channels for Micah Tapman include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Micah Tapman last invest?
The most recent investment recorded for Micah Tapman closed in Aug 2019. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
